Top compounds associated with response to DEFB4A


Feature Type Standardized
Nominal ANOVA
mRNA Obatoclax Mesylate CTRPv2 pan-cancer AAC 0.014 0.7
mRNA LRRK2-IN-1 CTRPv2 pan-cancer AAC -0.015 0.7
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.014 0.7
mRNA CHEMBL1222381 CTRPv2 pan-cancer AAC -0.014 0.7
mRNA FGIN-1-27 CTRPv2 pan-cancer AAC 0.031 0.7
mRNA ETP-46464 CTRPv2 pan-cancer AAC -0.018 0.7
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.015 0.7
mRNA indisulam CTRPv2 pan-cancer AAC 0.013 0.7
mRNA cimetidine CTRPv2 pan-cancer AAC -0.028 0.7
mRNA Nilotinib CTRPv2 pan-cancer AAC -0.015 0.7
Download CSV